Colon Cancer News and Research

Latest Colon Cancer News and Research

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

The simple practice of letters and a telephone call to patients who are due for a colonoscopy significantly improves adherence to endoscopic follow-up recommendations, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

30 Mar 2011

SHMT1 gene and folate deficiency increase risk for colon cancer

Offering a likely insight into how such cancers develop in humans - Cornell University researchers report they have identified a gene that increases the risk for colon cancer in laboratory mice when the animals' diets are deficient in folate.

30 Mar 2011

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer

Interventional radiologists have been the leaders in the use of intra-arterial yttrium-90 radioembolization, since its introduction in 2000, to treat liver cancer.

29 Mar 2011

Everist Genomics announces global launch of OncoDefender-CRC colorectal cancer assay

Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor.

28 Mar 2011

Researchers identify enzyme biomarker that can diagnose early colon cancer

A research team at the University of Colorado Cancer Center has identified an enzyme that could be used to diagnose colon cancer earlier. It is possible that this enzyme also could be a key to stopping the cancer.

28 Mar 2011

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor, a cholesterol-lowering drug, can prevent new colon tumors from forming after colon cancer surgery.

25 Mar 2011

New insights into multiple myeloma research

Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights into the events that lead to this form of cancer and could influence the direction of multiple myeloma research.

24 Mar 2011

Early diagnosis of colorectal cancer can minimize treatment side effects in survivors

Renato Lenzi, M.D., medical oncologist at The University of Texas MD Anderson Cancer Center and colon cancer survivor, knows only too well how important preventive methods are to beating colorectal cancer. After all, a routine colonoscopy saved his life.

24 Mar 2011

Jefferson begins patient recruitment for new clinical trail to prevent colon cancer

Thomas Jefferson University has started recruiting patients for a new National Cancer Institute-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer.

23 Mar 2011

Bowel cancer incidence set to rise: Research

According to the latest research from the Cancer Council, the incidence of bowel cancer in Australia is set to rise to 21,000 cases a year in the next decade. The report shows that one in five cases are diagnosed at an advanced stage, due to a lack of screening. This research is being used to renew the Federal Government’s full funding and implementation of the national bowel cancer screening program. Funding for the program is due to expire at the end of June.

21 Mar 2011

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Genomic Health, Inc. today announced results from nine studies utilizing the Oncotype DX test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland.

18 Mar 2011

Study: Stem cells may open door to new tools for colorectal cancer detection, treatment

Colorectal cancer cells trigger a set of genes similar to those found in intestinal stem cells, scientists at the Institute for Research in Biomedicine have found.

18 Mar 2011

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.

From Quest Diagnostics 18 Mar 2011

First ever light-activated, non-surgical treatment for HPV and pre-cancerous lesions of the cervix

A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.

16 Mar 2011

Number of cancer survivors rise: CDC report

Latest figures show that many Americans are surviving cancer. In fact, 40 percent of cancer survivors have outlived their diagnoses by 10 years or more.

12 Mar 2011

DiagnoCure first quarter total revenue is $362,101 for 2011

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.

11 Mar 2011

ITCs in vegetables appear to target and block p53 gene linked with cancer

Scientists are reporting discovery of a potential biochemical basis for the apparent cancer-fighting ability of broccoli and its veggie cousins. They found for the first time that certain substances in the vegetables appear to target and block a defective gene associated with cancer.

10 Mar 2011

Yakult Honsha, AEZS sign agreement to develop, commercialize and license perifosine

Aeterna Zentaris Inc. and Yakult Honsha Co., Ltd. today announced the signing of an exclusive development, commercialization and licensing agreement for the development, registration and marketing of perifosine, Aeterna Zentaris' lead anti-cancer compound, for Japan.

9 Mar 2011

EIF's NCCRA, SU2C to encourage people get screened for colorectal cancer

Golden Globe and Academy Award-nominated actor and musician Terrence Howard appears in a moving window display at Rockefeller Plaza this month, encouraging viewers to get screened for colorectal cancer as an ambassador for the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and Stand Up To Cancer.

5 Mar 2011

How cancer impacts patients and their partners

Katarina Sjövall has studied partners of individuals with colorectal cancer, lung cancer, breast cancer or prostate cancer. The study shows that the number of diagnosed diseases among partners increased by 25 per cent after the cancer diagnosis.

4 Mar 2011

Colon Cancer News and Research

Latest Colon Cancer News and Research

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

SHMT1 gene and folate deficiency increase risk for colon cancer

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer

Everist Genomics announces global launch of OncoDefender-CRC colorectal cancer assay

Researchers identify enzyme biomarker that can diagnose early colon cancer

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

New insights into multiple myeloma research

Early diagnosis of colorectal cancer can minimize treatment side effects in survivors

Jefferson begins patient recruitment for new clinical trail to prevent colon cancer

Bowel cancer incidence set to rise: Research

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Study: Stem cells may open door to new tools for colorectal cancer detection, treatment

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

First ever light-activated, non-surgical treatment for HPV and pre-cancerous lesions of the cervix

Number of cancer survivors rise: CDC report

DiagnoCure first quarter total revenue is $362,101 for 2011

ITCs in vegetables appear to target and block p53 gene linked with cancer

Yakult Honsha, AEZS sign agreement to develop, commercialize and license perifosine

EIF's NCCRA, SU2C to encourage people get screened for colorectal cancer

How cancer impacts patients and their partners

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Colon Cancer News and Research

Latest Colon Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in